The Bellevue and the Hagley Park mental health outpatient clinics in Jamaica serve the majority of psychiatric patients in the country, but there is a dearth of research on medication compliance, which is a very important mental health issue. Medication compliance affects intervention outcomes. Therefore, this study seeks to examine medication compliance among psychiatric patients in Jamaica. A 33-item questionnaire which included items on demographics, health conditions, medication compliance and insightfulness was administered to a sample of 370 participants with a response rate of 93%. The majority of the participants have schizophrenia, followed by depression, bipolar disorder and drug-induced psychosis. The majority of the participants (65.3%) did not comply with their prescribed medication regimen. Medication compliance was significantly related to: gender (P < 0.05) where males were more likely to take the prescribed medication, family support (P < 0.05) where the participants who received family support (the majority being males) were more likely to take the prescribed medication, and insightfulness (P < 0.05) where the majority of participants with insightfulness were females. Locus on control was not statistically tested but a majority of the non-compliant participants reported that factors external to themselves had greater control over their disorder. Conclusion: There are three significant factors that explain the medication compliance of psychiatric patients in Jamaica. An important non-tested factor is locus of control so there needs to be more research to understand the range of factors that can inform and improve patient education about medication compliance.
INTRODUCTION
Mental illness such as schizophrenia, bipolar disorders and uni-polar depression presents a serious health care problem in Caribbean countries such as Jamaica and worldwide. The economic, clinical, and personal burdens associated with schizophrenia make it a leading public health problem. The earliest epidemiological report on schizophrenia in the Caribbean was from Jamaica [1] , and indicated that the annual population incidence rate was 150 per 100,000. Burke [2] confirmed this finding, and reported an annual incidence rate of 136 per 100,000. Both studies were based on mental hospital admission rates, and it is likely that these studies failed to access the total number of admissions for the island. A study of psychiatric admissions to private and public hospitals across Jamaica [3] reported that the incidence rate of schizophrenia had fallen from 69 per 100,000 in 1960 to 35 per 100,000 in 1990.
Antipsychotic drugs, the most effective treatment for acute episodes or exacerbations of schizophrenic illness [4] , allow many patients to leave institutions and live in the community [5] . Rates of relapse among patients with schizophrenia who receive medication are two to three times lower than those among patients receiving placebo [6] , and non-compliance increases the frequency of acute psychotic episodes and psychiatric hospitalization [7] . Although antipsychotic drugs can have serious adverse effects [8] , many clinicians prescribe them at moderate doses for as long as possible to prevent relapse. In addition to antipsychotic agents, patients with schizophrenia may receive lithium, antidepressants, or benzodiazepines for concomitant psychiatric disorders [4] .
Mental health research and pharmaceutical innovation have developed a class of drugs referred to as "atypical Copyright © 2010 SciRes. JBiSE antipsychotics", which are used for the treatment of severe schizophrenics who are considered treatment-resistant to traditional or conventional antipsychotic medications, or who experience side-effects severe enough to require that the patient discontinue use of conventional antipsychotics [9] . These atypical antipsychotics are tremendously effective in combating the symptoms of schizophrenia while avoiding the severe side-effects often experienced through treatment with conventional antipsychotics [10] . In Jamaica medications for treating mental health problems are limited and their availability varies district by district. Older antipsychotic drugs are usually available, but there is only limited availability of the newer, more expensive anti-psychotics. In the North East, some patients are treated with clozapine by special arrangement by the district psychiatrist [11] . Adherence to drug regimen is a very important factor for improvement. Adherence may be defined as the extent to which a person's behaviour confirms to medical or health advice [12] . Patient who do not follow the treatment schedule and drug regimens prescribed to them by physician can be described as noncompliant or not adherent [13] . Medication compliance among bipolar disorder patients is related to the constructs of the health belief model (HBM) such as benefits and barriers, susceptibility and perceived seriousness [14] . However, the compliance/non-compliance of patients is only moderately predicted by the HBM. The HBM does not cover some determinants of medication compliance such as social influence and treatment alliance [15] . Patients with bipolar disorder who are medication compliant perceive the quality of their life to be higher, have greater resources to cope with stress and have a stronger belief that their behaviour controls their health status, unlike non-compliant patients [16] . The patients' perception of the medication is important because cognitive dissonance suggests that the perceptual properties of the medication have particular meanings for the patients. These meanings can support or distract the patients from medication compliance [17] . Patients with a major depressive disorder who have a superior medication compliance index are more likely to show improved scores on the Hamilton Depression Scale [18] . The medication events monitoring system (MEMS) used in a study with schizophrenic disorder patients reveals a 63% mean compliance rate for the first month and a decline from 56% to 45% over the next five months. The medication compliance of these patients can be monitored with electronic monitoring devices, but data recovery and compliance require methodological improvements [19] .
Among patients with psychotic disorders there was a significant relationship between medication adherence and involuntary admission, substance abuse, not graduating from school, and a history of abusive behaviour.
Patients with paranoid or negative symptoms were less compliant in taking their medication. However, patients who were changed from a typical to an atypical antipsychotic medication were more compliant than patients who remained on the typical antipsychotic medication. The patients who had higher medication compliance experienced much greater improvement of their psychiatric symptoms [20] . Medication self-management among patients with schizophrenia or affective disorder is important for medication compliance. However, patients who are self-managing their medication, guided by the principles of motivational interviewing, have better attitudes towards medications and insights about their illness compared to controls, but the group difference is not significant [21] .
Patients with schizophrenia, bipolar disorder and unipolar depression, who were educated about the nature of their disorder and its pharmacological management, were more compliant in outpatient follow-ups, and displayed less fear of being addicted to the medication and dealing with the side effects of the drug [22] . Severely mentally ill patients who were a part of the Medication Usage Skills for Effectiveness (MUSE) Program that taught cueing, life skill techniques, visual feedback and about the data displayed on the medication cap showed an overall mean compliance rate of 76%, compared to a 57% compliance rate for the control group [23] .
The problem of poor adherence to therapeutic regimen has been a matter of concern to the professionals for years. The paucity of data on cost-related medication adherence problems has important implications not only for estimating their clinical significance, but also for understanding the extent to which adherence problems vary across socioeconomic groups. To our knowledge there has not been any study that has examined drug compliance among mentally ill patients in Jamaica who are treated with oral antipsychotics. The aim of this study was to examine the medication compliance of psychiatric patients in Jamaica.
MATERIALS AND METHODS

Sample
In Jamaica the single mental hospital is Bellevue Mental Hospital in Kingston. Its three acute care wards of 50 beds each serve a designated geographic catchment area of the parishes of Kingston, St. Andrew, and St. Catherine, a population that is 70 percent urban [24] . Of the hospital's patients, 40% are older than 65 years, 60% of them are regarded as chronically ill, and 300 of them have lived in the hospital for most of their adult lives. The University Hospital West Indies (UHWI), also located in Kingston, has a 20-bed psychiatric unit. It is an acute unit with an average length of stay of 15 days. Ja-Copyright © 2010 SciRes. JBiSE maica's rural and western regions are served partly by Cornwall Regional Hospital. This 60-bed unit offers a full range of services, but only 30 beds are used because of staff shortages [11] . The Bellevue Hospital in Kingston and the Hagley Park Health Centre in Saint Andrew investigated in this study are two of the main psychiatric clinics in Jamaica. They attend to in excess of 90% of the psychiatric out-patient cases in the country. The current study used cross-sectional survey to gather the data from participants. Using a sampling error of ± 3.0% and a 95% confidence interval, the calculated sample size was 370 participants. Based on the proportionality of cases seen over the last 2 months, this was used to proportion the sample size from each institution: 200 participants from the Bellevue Hospital Clinic and 170 from the Hagley Park Health Centre. The response rate was 93.0% with 186 participants from the Bellevue Outpatient Clinic and 158 from the Hagley Park Health Centre.
Data was collected over a three-month period, from March to May, 2008 . A team of trained data collectors were retrained in keeping with the peculiarities of the task. The researcher was a part of the process, and regular checks were done to ensure consistency among interviewers. The inclusion/exclusion criterion was based on mental illness and medication use. Mentally ill patients who were visiting the clinics for the first time were excluded from the study because they would not have developed a pattern of medication compliance (or noncompliance).
The Instrument
A 33-item questionnaire was used to collect the data. The questions included: 1) demographic information, 2) medication compliance, 3) reasons for taking (or not taking) medication, 4) accessibility and affordability of medication, 5) use and prevalence of home remedies, 6) family support and 7) perception of the management of mental illness (Appendix 1).
Test-and-Pretesting the Instrument
The instrument was developed in consultation with academics at the University of the West Indies, Mona, Jamaica, caregivers/guardians at the Harbour View Health Centre in St. Andrew, health practitioners, and nonprospective mentally ill patients for the sample. The instrument was modified in keeping with the comments of the various stakeholders, with specific emphasis on mentally ill patients' perspectives, suggestions and recommendations. A pilot of 50 questionnaires was tested at the Harbour View Health Centre on ill patients, and they provided useful information regarding ambiguities, which was then used to modify the final instrument.
Measure
Non-compliance in medication denotes the failure or refusal of an individual to take the prescribed medication(s) as recommended by the medical practitioner. Compliance is adhering to the prescription of oral or other forms of medication as stipulated by the medical practitioner. It was measured using the item "I take my medication as instructed by the doctor." The options ranged from always, most times, occasionally and rarely, to never. Compliance for this study is taken to be only a response of 'always'.
Health condition is an illness or ailment diagnosed by the medical practitioner, and this was taken from the medical record of the participant. Insightfulness was measured by the questions: 1) "Do you have a sense of the likelihood of being ill or of when your illness is likely to occur?" 2) Should medication only be taken when one is experiencing symptoms of illness?" and 3) "Will counselling on how to take medications help you to take them better?" The options were yes, no, or unsure. If the answers to all three questions were yes, it was coded as insight, if no was selected in any question it was coded as lack of insight, and unsure was coded as undecided. Non-responses were treated as missing, and not included in any categorization.
Ethics and Informed Consent
The survey was submitted and approved by the University of the West Indies Medical Faculty's Ethics Committee. Participants and/or caregivers gave voluntary consent to their participation in the study. In order to ensure confidentiality, the personal information (i.e. name, address) of the participants was taken from the questionnaires and discarded, after which the other information was entered and stored for data-analysis.
Statistical
Percentages were used to provide background information on the demographic characteristics of the sample, knowledge of the medication and self-reported information. Chi-square tests were utilized to examine whether statistical associations existed between non-metric dependent and independent variables. A P-value of < 5% (i.e. 95% confidence interval) was used to determine the statistical associations between the variables.
RESULTS
Demographic Characteristic of Sample
There were 344 participants in the sample, of which 53.7% (n = 185) came from the Day Clinic at Bellevue Hospital and 64.2% (n = 159) came from the Hagley Park Health Centre. Most of the sample were diagnosed Copyright © 2010 SciRes. JBiSE with schizophrenic disorder (58.7%, n = 202), with other health conditions being depression (13.1%, n = 45), bipolar disorder (10.5%, n = 36), and drug-induced psychosis (4.7%, n = 16). Sixty-two percent (n = 212) of the sample had secondary level education; 64.8% were unemployed; 93.0% lived with either parents, partner, children, sibling or in a nursing home; 84.1% had family support; 80.5% were not in a union relationship (unmarried, 58.7%; separated, 13.4%: divorced, 4.6%; widowed, 3.8%); 10.5% were married; 44.7% complied with the instruments of the medical practitioners in regards to medication usage; and the mean age was 43.6 years (± 1.5 years).
The most common reasons among those who did not comply with the specifications of the medications (55.3%, n = 189) were 'medication makes me feel too drowsy' -19.0%; 'I was out of medication' -18.0%; 'I forgot' -16.9%; and 'medications make me feel worse' -10.1%.
The majority of the participants (76.2%, n = 262) indicated that they were able to purchase the medications. The participants indicated that if the medication was not available at the hospital or health centre, they would purchased them from a private pharmacy (65.1%), wait for the next appointment in order to see if it was now available (16.6%), and used a home remedy (0.6%).
According to Table 1 , no significant statistical relationship was found between the type of medical facility utilized and, gender, employment status, education or age (P > 0.05); nor for compliance (P > 0.05) or insightfulness (P > 0.05). However, an association did exist between the type of medical facility utilized and marital status (P < 0.05). Twenty-four percent of those who utilized the Hagley Park Health Care Centre were in intimate unions (relationships), compared to 15.6% of those who visited the Bellevue Hospital.
Gender was the only demographic variable that was associated with diagnosed health conditions (P < 0.05; Table 2 ). Most of the participants were diagnosed with schizophrenic disorder, with more males than females with the illness. Females were more likely to be diagnosed with bipolar disorder and depression than males. However, there were more males diagnosed with drug-induced psychosis (5.9%) than females (2.8%).
A statistical relationship was found between gender and compliance/non-compliance of participants (P < 0.05). Males were more likely to comply with the specifications of their medication (51%) than females (35.9%). In addition, significant statistical associations were found between family support and compliance/noncompliance (P < 0.05), and family support and gender of respondents (P < 0.05). Males (59.7%) had more family support compared with females (40.3%), and more of Approximate thirty seven percent (37.3%) of the participants were knowledgeable about the medication they were taking. Sixty-two percent of those who were knowledgeable about the medication indicated that they received the information from their medical doctors, 16.9% from pharmacists and 15.4% from nurses. Concurrently, when they were asked to state who was responsible for controlling their illness, one-half (50%) indicated their medical doctor was responsible for controlling their illness, nurse 10.5%, pharmacists 9.0%, God 9.0%, self 4.1%, and other 3.5%.
The majority of the participants indicated that apart from medication and other health care professionals, other factors that controlled their illness were: praying (52.4%), cigarettes (11.0%), smoking marijuana (10.5%), fasting (5.05), leaves from sour-sop tree (3.5%) and Obeah (0.3%). A cross-tabulation between gender and insightfulness revealed a significant statistical association (P < 0.05). Lacking insightfulness was greatest for males (68.6%) and insightfulness was greatest among f emales (50.0%).
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DISCUSSION
In this study, the majority of the participants were diagnosed with schizophrenia, followed by depression, bipolar disorder and drug induced psychosis which is consistent with other findings in the medical literature [1, 2] . The majority (84.1%) of the participants have family support, but of this amount only 54% complied with taking the medication as prescribed. This suggests that family support is a significant determinant of medication compliance. This finding corroborates that of Garcia and colleagues, that the support from family caregivers predicts the use of psychiatric medication [25] . According to Hickling [26] family members of mentally ill patients in Jamaica take on the ongoing tasks of monitoring the patient and supervising his or her medication program. Along with the patient and the community mental health service providers, family members participate in formulating and carrying out plans for treatment and vocational rehabilitation. Although such family involvement is not unique, the extent to which the Jamaican community mental health service has to rely on the extended family is noteworthy. Most (80.5%) of the participants were not in a stable intimate partner relationship, a fact which could have influenced the amount and the quality of social support they received. Possible explanations could be the negative stigma associated with mental disorders in Jamaica and their inability to provide financially in such a relationship, since 64.8% of the participants were unemployed. However, in Jamaica, the fear and stigma associated with mental illness has been greatly reduced, mental illness is openly discussed in the media, and patients are comfortable receiving treatment for a variety of psychiatric conditions in public and private community treatment facilities [27] .
Medication compliance among the participants in our study was very low with only 44.7% taking their medication. Among those participants who did not comply with the medication specifications (55.3%), 19% of this group indicated they experienced drowsiness, and 10.1% indicated that they felt worse. According to Feuertein et al. [28] estimates of noncompliance ranges between 4% and 92%, with average from 30 to 35 percent. The reason for non-compliance among the participants in this study could be due to a number of factors such as: discomfort resulting from treatment (side effects of medication), expense of treatment, problems of filling a prescription, decision based on personal value, judgment or religious or cultural beliefs about the advantages and Copyright © 2010 SciRes. JBiSE disadvantages of the proposed treatment, maladaptive personality, traits or coping style (for example the denial of illness), the stigma attached to drugs for mental health conditions and lack of understanding about the nature of the illness [29] . According to Demyttenwere, the dropout rate of psychiatric patients is attributed to various factors, such as illness and patient's characteristics, time taken to improve or poor doctor-patient relationship [30] . Mann indicated that the variance between what the doctors prescribe and what the patients take can be reduced by the doctor listening more carefully to the patients and addressing their concerns about the side effects of the medication [31] . In addition, educating the patients about their disorder, pharmacological management and addressing their concerns and fears of being addicted to the drug increases their compliance [32] . In our study, 18% among the noncompliant participants suggested that their medication was finished, and 16.9% indicated that they forgot to take their medication. These patients can be instructed about life skill techniques, cueing, about NS not significant the medication data displayed on the cap, and about audiovisual feedback as this kind of instruction increases medication compliance among psychiatric patients [33] . Interventions to increase medication compliance through patient education in Jamaica are necessary because only a minority (37.3%) of the participants reported that they were knowledgeable about the medication they were taking, and the majority (76.2%) of the participants in dicated that they were able to buy their medication, so the cost of the drug was not a prohibitive factor. Medical doctors can play a major role in this regard because 62.0% of the participants who were knowledgeable Copyright © 2010 SciRes. JBiSE about their medication stated that they received information from their doctor.
There is a significant relationship between marital status and the clinic used, because 24.0% of the participants used the Hagley Park Health Centre Clinic compared to 15.6% for the Bellevue Clinic. This is a surprising finding which requires more research. One possible explanation for this finding is that the Bellevue Hospital is the oldest and only major psychiatric hospital in Jamaica. It is heavily stigmatized given the very negative perception Jamaicans have toward mental disorders and people with mental disorders. Therefore, it is possible that the married participants attended the Hagley Park Clinic to avoid the very negative stigma associated with the Bellevue Clinic.
Many chronically ill patients take less of their medication than has been prescribed, owing to cost concerns, especially those patients with low incomes, multiple chronic health problems, or no prescription drug coverage [34] . The consequences of cost-related medication underuse include increased emergency department visits, psychiatric admissions, nursing home admissions, as well as decreased health status [35] . In Jamaica there is government assistance for low-income patients. According to McKenzie, few patients ask for it. In his study, in one clinic, none of those who were prescribed medication (at least 35) asked for assistance, despite the fact that none of them were working. It is customary for families to pay for their relatives' medication. Caregivers considered a lack of money and the need to pay for prescriptions as a deterrent for attending the clinic [11] .
There is a significant relationship between gender and psychiatric disorder which is an unexpected finding. A majority of males and females were diagnosed with schizophrenia, with a higher incidence among males. More males than females were diagnosed with druginduced psychosis, while more females were diagnosed with depression and bipolar disorder than males. Further research is required to understand the nuances of the relationship between gender and mental disorder which is an under-researched area. In addition, there is a related significant relationship between gender and medication compliance, in which males were more likely to comply with their medication. This finding may be explained by the significant relationship between insightfulness about medication and gender, where males account for 68.0% of the participants who lacked insightfulness. This finding suggests that it is possible that there is greater medication compliance among males, because they are less insightful about their medication and its side effects than females. It is also possible that since the majority (59.7%) of participants with family support are males, the social support increases medication compliance in this group [25] .
In the present study, non-compliance of medicationtaking among those with bipolar disorder and depression was over 80%. Lack of insight [36] is a factor associated with poor drug compliance. Hummer and Fleischacker [37] explained that non-compliance with medication is owing to the patients' perception that the illness is not serious to enough to warrant treatment compliance. Conversely, a study by Cramer and Rosenheck found that 58% of those diagnosed with psychosis and 65% of those with depression complied with the treatment prescription [38] , which is significantly higher than a similar group in Jamaica. One researcher admitted that the side effects of neuroleptics are real, but can be managed [39] , which clearly is accepted by those diagnosed with drug psychosis and bipolar disorder in Jamaica Patients' belief in their ability to control their illness is very important for medication compliance. However, the participants in our study believed in a range of external factors apart from medication that could be used to control their disorder. These external factors are: praying, use of Obeah (Jamaican witchcraft), fasting, smoking marijuana or use of sour-sop leaves, and smoking cigarettes. There are also some participants (69.5%) who believed that doctors, nurses and pharmacists were responsible for controlling their disorder. Thus the majority of the participants in our study displayed an external locus of control (rather than an internal locus of control) which downplays the belief that they themselves have major control over what happens in their lives and their wellbeing. This can clearly has an effect on medication compliance. These findings are corroborated by the findings of Volis and colleagues, that the locus of control is important in medication compliance because it mediates the relationship between medication compliance and social support [40, 41] .
This study has contributed to the literature by unearthing a range of factors that are significantly related to medication compliance among psychiatric patients in Jamaica, which increases our understanding of this very important health issue. There are some limitations to our study. While our sample was taken from the two public mental health clinics that treat the majority of psychiatric cases in the country, these clinics are located in the metropolitan region of Kingston. Therefore, it is possible that our sample did not capture psychiatric patients from other urban centres and rural areas. Therefore only cautious generalizations should be made. In addition, there is the possibility of social desirability bias, where some of the patients told the interviewers what they wanted to hear to get their approval. It is also possible that the patients' mental disorders affected the accuracy of their self-reports. Despite the aforementioned fact, medication non-compliance among schizophrenic patients in this research was low and in keeping with another in a nonCaribbean nation which found that it ranges between Copyright © 2010 SciRes. JBiSE 24-90% [42] . This work also concurs with the findings of the Jamaican Ministry of Health, which found that medication compliance among schizophrenia patients in Jamaica was 69% [43].
CONCLUSIONS
Medication compliance among males is about average, but is extremely low among females. The majority of the participants with an average age of 43.6 years from the Bellevue and Hagley Park mental health outpatient clinics do not comply with their medication regimen for schizophrenia, bipolar disorder, depression and psychosis among other disorders. This non-compliance can be explained by three significant factors. These are gender, which is related to the factor of reduced insightfulness about taking medication and family support. Non-compliance may also be explained by the locus of control which was not tested in this study, but the majority of the noncompliant participants believe that factors external to them have greater control over their illness than they do. The current study highlights the challenge for public health practitioners and policy makers in addressing this high non-compliance of medication among the mentally ill in Jamaica. A pertinent finding of this study is the fact that the level of education did not change compliance (or non-compliance) among mentally ill patients, suggesting that there is a need for more research to unearth the range of factors that influence medication compliance, the belief system of mentally ill patients, an examination of alternative approaches to the treatment of mental illness, and a social intervention programme that is geared towards holistic education strategies in patient care. What is evident from the study is the fact that medication compliance can be explained by 1) the perception of the severity of the illness and the usefulness of the relevant medication, and 2) the perceived side-effects of prescribed medications. Medication non-compliance places mentally ill patients at great risk of exacerbation of their symptoms, homelessness and interruptions in their daily lives, so much so that this has become a public health concern which must be addressed with urgency and care. Family support emerged as a positive determinant of medication compliance, suggesting that public health practitioners must begin to explore the role of social support in treating mentally ill individuals, as well as aiding in the drive for increased medication compliance among these individuals.
